GRC 27864

DRUG2 trials

Sponsors

Glenmark Pharmaceuticals Ltd. India, Glenmark Pharmaceuticals S.A.

Conditions

Healthy

Phase 1

GRC 27864 First in Man, Single Ascending Dose Study in Healthy Volunteers

CompletedNCT02179645

Glenmark Pharmaceuticals Ltd. IndiaHealthy

Start: 2014-05-31End: 2014-12-31Updated: 2014-12-30

To Evaluate Safety, Tolerability and Pharmacokinetics of GRC 27864 in Healthy Subjects and Elderly Healthy Subjects

CompletedNCT02361034

Glenmark Pharmaceuticals S.A.Healthy

Start: 2015-01-31End: 2015-09-30Updated: 2015-12-15